Market Cap (In CNY)
8.41 Billion
Revenue (In CNY)
1.18 Billion
Net Income (In CNY)
104.65 Million
Avg. Volume
34.2 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.71-9.82
- PE
- -11.72
- EPS
- -0.53
- Beta Value
- 0.579
- ISIN
- CNE000001KP1
- CUSIP
- -
- CIK
- -
- Shares
- 1371130000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Luo Huang
- Employee Count
- -
- Website
- https://www.daangene.com
- Ipo Date
- 2004-08-09
- Details
- Daan Gene Co., Ltd. researches and develops, manufactures, and sells clinical test reagents and instruments. The company offers fluorescence quantitative PCR products, time resolution series products, enzyme-linked immunoassay products, instrument products, and scientific research service products. It also provides medical examination, and health consultation and management services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. The company was founded in 2001 and is headquartered in Guangzhou, the People's Republic of China.
More Stocks
-
ARKA
-
SRCH
-
002848
-
BBIGVinco Ventures, Inc.
BBIG
-
EVVL
-
5071VIS Co., Ltd.
5071
-
0VHAShopify Inc.
0VHA
-
000910